Popular Weight‑Loss Drugs May Pose Risks for Some Patients
Summary
GLP-1 weight-loss drugs like Ozempic and Wegovy are commonly used in the U.S. to treat type 2 diabetes and obesity. While effective for many, these drugs can cause side effects such as slow stomach emptying (gastroparesis) and may not be safe for patients with certain chronic conditions like Ehlers-Danlos Syndrome or Postural Orthostatic Tachycardia Syndrome.Key Facts
- GLP-1 drugs mimic a natural hormone that helps control blood sugar and feelings of fullness.
- About one in eight Americans used these drugs as of March 2026.
- They can slow the stomach’s emptying process, increasing the risk of gastroparesis, which causes nausea, vomiting, and stomach pain.
- Patients with conditions like Ehlers-Danlos Syndrome and PoTS are more prone to digestive problems from these drugs.
- Some patients may need special diets to reduce symptoms while using GLP-1 drugs.
- Appetite suppression from these drugs could be risky for people requiring more calories and protein due to chronic illnesses.
- Sudden, large weight loss may have additional health effects not fully understood.
- Medical supervision and careful patient screening are important when using GLP-1 drugs.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.